Literature DB >> 1283445

Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer's disease.

P D Coleman1, A M Kazee, L Lapham, T Eskin, K Rogers.   

Abstract

We previously suggested the hypothesis that defective neuronal plasticity is a major neurobiological deficit causing the dementia of Alzheimer's disease (AD). We used message levels of the growth-associated protein, GAP-43, as a marker of axonal plasticity to examine the hypothesis of defective neuronal plasticity in AD. When all AD cases are combined, the average level of GAP-43 message in area 9 of the AD frontal association cortex was not significantly different from the level in the comparably aged control cortex. Differentiation of AD cases on the basis of neurofibrillary tangle (NFT) density revealed that in AD cases with high tangle density average GAP-43 message level was reduced fivefold relative to levels in AD cases with low NFT density. AD cases with low neurofibrillary tangle density had levels of GAP-43 message that were not significantly different from the levels of normal controls. Differentiation of AD cases on the basis of neuritic plaque density did not indicate as strong a relationship to GAP-43 message level. The association between neurofibrillary tangle density and GAP-43 message level suggests the hypothesis that neurofibrillary tangles may reduce GAP-43 expression. Data of others show a relationship between high NFT density and reduced levels of synaptophysin-like immunoreactivity and reduced cerebral glucose metabolism. These data combine to suggest a set of AD cases with high NFT density, reduced axonal plasticity, reduced synaptic density, and reduced cerebral glucose metabolism--all variables that may be directly related to the functioning of the brain.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283445     DOI: 10.1016/0197-4580(92)90085-c

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  Aberrant GAP-43 gene expression in Alzheimer's disease.

Authors:  S M de la Monte; S C Ng; D W Hsu
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

2.  Synaptic proteins, neuropathology and cognitive status in the oldest-old.

Authors:  Elizabeth Head; Maria M Corrada; Kristin Kahle-Wrobleski; Ronald C Kim; Floyd Sarsoza; Matthew Goodus; Claudia H Kawas
Journal:  Neurobiol Aging       Date:  2007-11-14       Impact factor: 4.673

3.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

4.  Truncated tau deregulates synaptic markers in rat model for human tauopathy.

Authors:  Santosh Jadhav; Stanislav Katina; Andrej Kovac; Zuzana Kazmerova; Michal Novak; Norbert Zilka
Journal:  Front Cell Neurosci       Date:  2015-02-23       Impact factor: 5.505

Review 5.  A Shift from a Pivotal to Supporting Role for the Growth-Associated Protein (GAP-43) in the Coordination of Axonal Structural and Functional Plasticity.

Authors:  Matthew R Holahan
Journal:  Front Cell Neurosci       Date:  2017-08-31       Impact factor: 5.505

6.  Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression.

Authors:  L Buizza; C Prandelli; S A Bonini; A Delbarba; G Cenini; C Lanni; E Buoso; M Racchi; S Govoni; M Memo; D Uberti
Journal:  Cell Death Dis       Date:  2013-02-07       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.